Ampio Pharma Stock Price, News & Analysis
Company Description
Ampio Pharma (OTC Link: AMPE) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $3.1K.
AMPE stock has gained 25333.3% over the past year. Shares last traded at $0.1525.
On a trailing twelve-month basis, Ampio Pharma reported net income of -$8.6M and diluted earnings per share of $-10.66.
This page provides a comprehensive overview of AMPE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ampio Pharma (AMPE) stock last traded at $0.1525. Over the past 12 months, the stock has gained 25333.3%. At a market capitalization of $3.1K, AMPE is classified as a micro-cap stock with approximately 1.1M shares outstanding.
Latest News
Ampio Pharma has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, clinical trial, stock split, dividends. View all AMPE news →
SEC Filings
Financial Highlights
net income was -$8.6M. Diluted earnings per share stood at $-10.66. The company generated -$8.6M in operating cash flow. With a current ratio of 2.41, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Ampio Pharma (AMPE) currently stands at 25 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 58.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Ampio Pharma (AMPE) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
AMPE Company Profile & Sector Positioning
Ampio Pharma (AMPE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AMPE often look at related companies in the same sector, including BETTER THERAPEUTICS INC (BTTX), Gritstone Bio Inc (GRTSQ), Novaccess Global Inc (XSNX), Statera Biopharma Inc (STAB), and Renovacare (RCAR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AMPE's relative position within its industry.